DE3479890D1 - Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions - Google Patents

Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions

Info

Publication number
DE3479890D1
DE3479890D1 DE8484401793T DE3479890T DE3479890D1 DE 3479890 D1 DE3479890 D1 DE 3479890D1 DE 8484401793 T DE8484401793 T DE 8484401793T DE 3479890 T DE3479890 T DE 3479890T DE 3479890 D1 DE3479890 D1 DE 3479890D1
Authority
DE
Germany
Prior art keywords
purine
preparation
application
viral compositions
pyrophosphates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484401793T
Other languages
English (en)
Inventor
Malcolm Maccoss
Richard Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3479890D1 publication Critical patent/DE3479890D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65746—Esters of oxyacids of phosphorus the molecule containing more than one cyclic phosphorus atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8484401793T 1983-09-19 1984-09-11 Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions Expired DE3479890D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/533,676 US4670424A (en) 1983-09-19 1983-09-19 Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides

Publications (1)

Publication Number Publication Date
DE3479890D1 true DE3479890D1 (en) 1989-11-02

Family

ID=24126983

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484401793T Expired DE3479890D1 (en) 1983-09-19 1984-09-11 Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions

Country Status (4)

Country Link
US (1) US4670424A (de)
EP (1) EP0138656B1 (de)
JP (1) JPS6087298A (de)
DE (1) DE3479890D1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US4845084A (en) * 1984-01-26 1989-07-04 Merck & Co., Inc. Phosphate derivatives of substituted butyl guanines, antiviral compositions containing them, and methods of treating viral infections with them
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
US5650510A (en) * 1986-11-18 1997-07-22 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
CA2171868A1 (en) * 1993-09-17 1995-03-23 Petr Alexander Method for dosing therapeutic compounds
US5798340A (en) 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
CN100537581C (zh) * 2004-06-18 2009-09-09 北京大学 环焦磷酸酯类化合物及其制备方法
JP5932829B2 (ja) 2010-12-10 2016-06-08 シグマファーム ラボラトリーズ エルエルシー 経口活性ヌクレオチドアナログ又は経口活性ヌクレオチドアナログプロドラッグの高度に安定な組成物
US20140142052A1 (en) * 2012-05-17 2014-05-22 Normoxys, Inc. Phosphorylated polyols, pyrophosphates, and derivatives thereof having biological activity
CN113024559B (zh) * 2019-12-25 2022-03-29 上药康丽（常州）药业有限公司 一种异更昔洛韦的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4731069Y1 (de) * 1969-01-27 1972-09-18
US4287188A (en) * 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
ZA837287B (en) * 1982-09-30 1984-11-28 Syntex Inc 1-monophosphate esters,1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents

Also Published As

Publication number Publication date
EP0138656A1 (de) 1985-04-24
EP0138656B1 (de) 1989-09-27
JPS6087298A (ja) 1985-05-16
US4670424A (en) 1987-06-02

Similar Documents

Publication Publication Date Title
DE3479890D1 (en) Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions
GR3021389T3 (en) Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
NZ213528A (en) Purine derivatives and pharmaceutical compositions
IL78643A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
AR242572A1 (es) Procedimiento para compuestos de 1-¡(isoxazolil o furanil)alquil o alcoxi¿-4-(4,5-dihidrooxazolil o 5,6-dihidro-4h-oxazolil)-2,6-disustituido fenilo.
ZA846525B (en) (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
DE3473875D1 (en) Pyrimidine derivatives, preparation thereof and use thereof
EP0137242A3 (en) (substituted) phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
IL86007A0 (en) 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
NZ220132A (en) Pyrimidine derivatives and pesticidal compositions
IL68133A0 (en) Substituted 1h-pyrazolo(1,5-a)pyrimidines,their preparation and pharmaceutical compositions containing them
IL76546A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL71679A (en) Antiviral compositions containing hydroxyethylazolyl derivatives and their preparation
DE3571810D1 (en) Substituted butyl guanines and their utilization in antiviral compositions
ZA814139B (en) Novel adenine nucleoside derivatives their preparation and pharmaceutical compositions containing them
IL74803A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL72716A (en) 5-phenylcarbamoyl barbituric acid derivatives,their preparation and anthelmintic compositions containing them
ZA804967B (en) Propenimidates, their preparation and rerrangement to pyrimidines
PH23367A (en) Purine derivatives,composition and method of use thereof
IL73121A (en) Pyridine,pyrazine and pyrimidine derivatives,their preparation and fungicidal compositions containing them
DE3166449D1 (en) Pyrimidine derivatives, their preparation and medicaments containing them
DE3162644D1 (en) Novel adenine nucleoside derivatives, their preparation and pharmaceutical compositions containing them
IL70651A0 (en) Carboxy-thiazolo(3,2-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL57300A0 (en) Arylalkyl-and aryloxyalkylphosphonates,their preparation and antiviral compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee